A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Trial Of Pregabalin As Adjunctive Therapy In Pediatric And Adult Subjects With Primary Generalized Tonic-clonic Seizures - Protocol A0081105
Phase of Trial: Phase III
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Tonic-clonic epilepsy
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Pfizer
- 07 Aug 2017 Planned End Date changed from 2 Nov 2017 to 19 Mar 2019.
- 07 Aug 2017 Planned primary completion date changed from 2 Nov 2017 to 19 Mar 2019.
- 02 May 2017 Planned End Date changed from 9 Dec 2017 to 2 Nov 2017.